written on 14.04.2014

AbbVie, Gilead, Janssen dazzle with Hep C data


A clutch of presentations at the International Liver Conference of the European Association for the Study of the Liver (EASL) over the weekend served to underline the impressive arsenal of new weapons that the pharma industry is preparing to unleash…